David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.95% |
| 2 | Healthcare | 11.57% |
| 3 | Consumer Discretionary | 9.23% |
| 4 | Communication Services | 8.8% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Mercer International
MERC
$28.6M
| $4.76M | 0.01% |
332,577
-21,725
| -6% | -$298K |
|
|
CRAY
1477
DELISTED
Cray, Inc.
CRAY
| $4.75M | 0.01% |
196,348
-17,431
| -8% | -$369K |
|
|
ECOM
1478
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $4.74M | 0.01% |
526,699
-593
| -0.1% | -$5.87K |
|
1479
PUT
The Mosaic Company
MOS
$7.72B
| $4.73M | 0.01% |
184,500
-88,300
| -32% | -$2.03M |
|
1480
Minerals Technologies
MTX
$2.24B
| $4.73M | 0.01% |
68,716
+38,719
| +129% | +$2.75M |
|
1481
CALL
Zions Bancorporation
ZION
$9.86B
| $4.73M | 0.01% |
93,000
| – | – |
|
|
EBIX
1482
DELISTED
Ebix Inc
EBIX
| $4.72M | 0.01% |
59,588
-19,616
| -25% | -$1.43M |
|
|
PINC
1483
DELISTED
Premier
PINC
| $4.72M | 0.01% |
161,703
+3,131
| +2% | +$96.5K |
|
1484
PUT
T-Mobile US
TMUS
$195B
| $4.71M | 0.01% |
74,100
-1,400
| -2% | -$85.4K |
|
1485
CALL
Vale
VALE
$65.2B
| $4.7M | 0.01% |
384,300
-215,700
| -36% | -$2.29M |
|
1486
CALL
XPO
XPO
$22.5B
| $4.7M | 0.01% |
148,329
+868
| +0.6% | +$22.2K |
|
1487
State Street SPDR S&P Regional Banking ETF
KRE
$4.04B
| $4.68M | 0.01% |
+79,581
| New | +$4.57M |
|
|
ASRT
1488
DELISTED
Assertio
ASRT
| $4.68M | 0.01% |
9,694
+3,881
| +67% | +$1.51M |
|
1489
Precigen
PGEN
$2.61B
| $4.68M | 0.01% |
406,357
-105,387
| -21% | -$1.57M |
|
1490
Ameren
AEE
$29.6B
| $4.67M | 0.01% |
79,177
+52,023
| +192% | +$3.2M |
|
|
BBBY
1491
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
| $4.66M | 0.01% |
211,800
+60,000
| +40% | +$1.3M |
|
1492
CALL
Newell Brands
NWL
$2.53B
| $4.63M | 0.01% |
+150,000
| New | +$5.17M |
|
|
GWPH
1493
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $4.63M | 0.01% |
35,100
| – | – |
|
|
TSRO
1494
PUT
DELISTED
TESARO, Inc.
TSRO
| $4.63M | 0.01% |
55,900
+21,400
| +62% | +$2.1M |
|
1495
PUT
Spectrum Brands
SPB
$2.05B
| $4.62M | 0.01% |
41,100
+2,400
| +6% | +$262K |
|
1496
BioCryst Pharmaceuticals
BCRX
$2.51B
| $4.61M | 0.01% |
939,473
-552,844
| -37% | -$2.68M |
|
1497
Pembina Pipeline
PBA
$28B
| $4.61M | 0.01% |
127,530
-71,865
| -36% | -$2.49M |
|
1498
PUT
Williams-Sonoma
WSM
$27.6B
| $4.6M | 0.01% |
177,800
| – | – |
|
|
CNACU
1499
DELISTED
Constellation Alpha Capital Corp. Unit
CNACU
| $4.58M | 0.01% |
450,000
| – | – |
|
1500
The Bancorp
TBBK
$2.73B
| $4.58M | 0.01% |
463,530
+148,768
| +47% | +$1.36M |
|
Similar funds
David Shaw's Q4 2017 Portfolio in Review
As of Q4 2017, David Shaw held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- David Shaw's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- David Shaw added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- David Shaw's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- David Shaw fully exited Tesla in Q4 2017, selling an estimated $230M.
- David Shaw's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- David Shaw opened 507 new positions and closed 394 in Q4 2017.
- David Shaw's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.